Ping-Ching Hsu
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
-
- Metabolomics and Mass Spectrometry Studies 4
- Epigenetics and DNA Methylation 4
-
- Smoking Behavior and Cessation 2
- Co-authors
- Peter G. Shields (5 shared papers)Chi‐Yuan Li (5 shared papers)Amrita K. Cheema (3 shared papers)Eryn K. Matich (4 shared papers)Habtom W. Ressom (3 shared papers)Wallace B. Pickworth (3 shared papers)L. Joseph Su (3 shared papers)Issam Makhoul (4 shared papers)
- Journals
- Anesthesia & Analgesia (4 papers)Molecular Carcinogenesis (2 papers)Cancers (2 papers)Environmental Pollution (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesTaiwanRomania
In The Last Decade
Ping-Ching Hsu
29 papers receiving 369 citations
Peers
Comparison fields: 5 of 86
- Chemical Health and Safety 2
- Cardiology and Cardiovascular Medicine 48
- Physiology 53
- Health, Toxicology and Mutagenesis 24
- Immunology 35
Countries citing papers authored by Ping-Ching Hsu
This map shows the geographic impact of Ping-Ching Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping-Ching Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping-Ching Hsu more than expected).
Fields of papers citing papers by Ping-Ching Hsu
This network shows the impact of papers produced by Ping-Ching Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping-Ching Hsu. The network helps show where Ping-Ching Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping-Ching Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 53 | |
| 2 | Biomarkers of inflammation, hypercoagulability and endothelial injury predict early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer patients. | 2020 | 45 |
| 3 | 2016 | 43 | |
| 4 | 2012 | 35 | |
| 5 | 2003 | 20 | |
| 6 | 2005 | 18 | |
| 7 | 2002 | 17 | |
| 8 | 2003 | 16 | |
| 9 | 2004 | 13 | |
| 10 | 2001 | 12 | |
| 11 | 2022 | 11 | |
| 12 | 2016 | 11 | |
| 13 | 2021 | 9 | |
| 14 | 2020 | 9 | |
| 15 | 2019 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2003 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2019 | 6 | |
| 20 | 2024 | 5 |
About Ping-Ching Hsu
Ping-Ching Hsu is a scholar working on Molecular Biology, Physiology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis, having authored 30 papers that have together received 374 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (4 papers), Epigenetics and DNA Methylation (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Health, Environment, Cognitive Aging (3 papers), Folate and B Vitamins Research (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Smoking Behavior and Cessation (2 papers) and Pesticide Exposure and Toxicity (2 papers). The work is most often cited by research in Chemical Health and Safety (2 citations), Cardiology and Cardiovascular Medicine (48 citations), Physiology (53 citations), Health, Toxicology and Mutagenesis (24 citations) and Immunology (35 citations). Ping-Ching Hsu has collaborated with scholars based in United States, Taiwan and Romania. Frequent co-authors include Peter G. Shields, Chi‐Yuan Li, Amrita K. Cheema, Eryn K. Matich, Habtom W. Ressom, Wallace B. Pickworth, L. Joseph Su, Issam Makhoul, Chien‐Sung Tsai and Chih‐Shung Wong. Their work appears in journals such as Anesthesia & Analgesia, Molecular Carcinogenesis, Cancers, Environmental Pollution and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.